Healthcare Activos buys across Europe to extend real estate platform
Spain-based European investment platform Healthcare Activos has acquired €150 million+ worth of healthcare assets by purchasing seven care properties across France, Italy, Portugal, and Spain, marking a significant milestone in its pan-European expansion strategy. The transaction, which includes two newbuild facilities, expands the company’s portfolio to a total assets under management value of €1.3 billion, demonstrating robust growth momentum in…
Bupa creates tri-hospital hub with King Edward VII’s Hospital acquisition
Bupa is acquiring King Edward VII’s Hospital, a high-profile private facility in London’s Harley Street district, marking a strategic expansion of its secondary care footprint in the UK capital. The deal, expected to close by end-2025, adds the hospital’s 56 beds, three operating theatres, diagnostic clinic, and specialized outpatient facility – launched in 2022 – to Bupa’s growing network.…
Amethyst Healthcare acquires Portuguese radiotherapy group Júlio Teixeira
Amethyst Healthcare has acquired Júlio Teixeira, a well-established provider of radiotherapy services operating in Porto and Braga. This acquisition forms part of its strategic expansion in Western Europe and will strengthen the group’s capacity to deliver advanced radiotherapy care in Portugal. Announced on October 6, 2025, the deal represents a significant strategic milestone in Amethyst’s expansion across Western Europe and…
Eugin expands Brazilian footprint with acquisition of Clínica Fertilidade e Vida
Spain-based Eugin Group, a global leader in reproductive medicine backed by Buenavista Equity Partners, has expanded its Latin American presence through the acquisition of Brazil’s Clínica Fertilidade e Vida. Eugin now operates over 30 centres across Europe (including Portugal, Italy, Sweden, Denmark, and Latvia) with a growing presence in Latin America. Clínica Fertilidade e Vida is a prominent reproductive medicine…
Spanish competition agency vetoes “competition threatening” radiopharma deal
Spain’s competition agency (CNMC) has prohibited Curium Pharma Holding Spain (Curium), a global leader in nuclear medicine, from acquiring Institut de Radiofarmacia Aplicada de Barcelona (IRAB). It said on Monday, October 6 that the merger poses an obstacle to effective competition in the markets for PET radiopharmaceuticals which are used in cancer detection tests, and contract manufacturing services to third…
Spire Healthcare weighs strategic options amid shareholder pressure
Spire Healthcare’s board has confirmed it is “actively evaluating appropriate action that could drive long-term shareholder value,” appointing Rothschild & Co to examine avenues that include a potential sale of the UK’s second-largest private hospital operator. The announcement triggered an immediate market response: Spire shares jumped as much as 13 % to 245p, lifting the group’s market capitalisation to £872m before dropping.…
CapVest Partners acquiring €10bn pharma group STADA Arzneimittel
European investment firm CapVest Partners has secured a definitive agreement to acquire a majority (70%) stake in STADA Arzneimittel AG from private equity firms Bain Capital and Cinven, valuing the German pharmaceutical giant at approximately €10bn including debt. The transaction positions CapVest as the new controlling shareholder while Bain Capital and Cinven retain minority stakes after eight years of ownership, reflecting their continued confidence…